Weaning From Prolonged Mechanical Ventilation
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Patients requiring the use of artificial ventilation (also called mechanical ventilation) for more than 21 days account for more than 37% of all ICU costs. As such, these patients are now transferred to centers that specialize in weaning patients from the respirator; these units are referred to as long-term acute care (LTAC) facilities. Despite the increase of LTAC facilities, research on the fastest method for disconnecting the patient from the respirator is lacking. In addition, little information is available regarding the long-term survival and quality of life after a prolonged course of artificial ventilation. The purpose of this study is to determine the fastest method for disconnecting the patient from the respirator at a LTAC facility and its effect on long-term survival and quality of life.
| Condition | Intervention |
|---|---|
|
Acute Mechanical Ventilatory Failure |
Other: Weaning |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Investigator) Primary Purpose: Treatment |
| Official Title: | Weaning From Prolonged Mechanical Ventilation |
- Weaning duration [ Time Frame: From the first day of randomization to the day the patient was successfully weaned up to 5 days ] [ Designated as safety issue: No ]
- mortality [ Time Frame: 6 and 12 month ] [ Designated as safety issue: No ]
| Enrollment: | 500 |
| Study Start Date: | October 2000 |
| Study Completion Date: | October 2011 |
| Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Pressure support
Patients randomized to the pressure support arm will wean using pressure support ventilation. The level of pressure support will be decreased by 2 cm H2O every 6 hours. The maximum decrement in pressure support permitted in one day will be 6 cm H2O.
|
Other: Weaning
Decrease assistance provided by the ventilator
Other Names:
|
|
Active Comparator: Spontaneous Breathing
Patients randomized to spontaneous breathing arm will be disconnected from the ventilator and allowed to breathe spontaneously through the tracheostomy. Duration of the trial will be increased sequentially as tolerated.
|
Other: Weaning
Decrease assistance provided by the ventilator
Other Names:
|
Detailed Description:
Patients requiring prolonged mechanical ventilation (defined as more than 21 days) account for more than 37% of all ICU costs. As such, these patients are now transferred to centers that specialize in weaning from mechanical ventilation, so called long-term acute care (LTAC) facilities. Despite the proliferation of LTAC facilities, research on methods for expediting weaning is lacking. In addition, little information is available regarding long-term survival and patient's perception of quality of life after a prolonged course of mechanical ventilation.
In patients receiving mechanical ventilation in an ICU, randomized trials have revealed that ventilator duration was significantly influenced by weaning methods. The two most common weaning methods are pressure support and spontaneous breathing trials. Unlike the ICU, the relative efficacy of these two techniques in weaning patients requiring prolonged ventilation at a LTAC facility is largely unknown. The aim of this proposal is to determine whether the length of time required for weaning from prolonged ventilation differs with pressure support versus spontaneous breathing trials. The second aim is to determine the long-term impact of prolonged ventilation on survival, functional status and quality of life.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Mechanical Ventilation for at least 21 days
Exclusion Criteria:
- Hypoxemia (oxygen saturation < 90% with fractional inspired O2 concentration > 0.40, and positive end-expiratory pressure > 5 cm H2O
- Hemodynamic instability (requiring intravenous vasoactive agents, such as dopamine > 5 mg/kg/min)
- Profound neurological deficits (large stroke)
- Documented bilateral phrenic nerve injury
- Previous admission to RML Hospital
- Life expectancy less than 3 months
Contacts and Locations| United States, Illinois | |
| RML Specialty Hospital | |
| Hinsdale, Illinois, United States, 60521 | |
| Principal Investigator: | Amal Jubran, MD | RML Specialty Hospital |
More Information
No publications provided by RML Specialty Hospital
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Amal Jubran, Attending Physician, RML Specialty Hospital |
| ClinicalTrials.gov Identifier: | NCT01541462 History of Changes |
| Other Study ID Numbers: | AXJ001, 5R01NR008782 |
| Study First Received: | February 16, 2012 |
| Last Updated: | February 23, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by RML Specialty Hospital:
|
mechanical ventilation weaning pressure support |
spontaneous breathing Long-term acute care facility mortality |
Additional relevant MeSH terms:
|
Hypoventilation Respiratory Insufficiency Respiration Disorders |
Respiratory Tract Diseases Signs and Symptoms, Respiratory Signs and Symptoms |
ClinicalTrials.gov processed this record on May 19, 2013